BHCFX Mutual Fund

NAV$21.71
Showing 10 of 41 holdings(as of Mar 31, 2026)Top 10 Weight: 43.86%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1LLYEli Lilly & Co9.95%13,000$11.96M••••••••••••••••••••••
2AZN:LNAstraZeneca PLC5.09%31,000$6.11M••••••••••••••••••••••
3JNJJohnson & Johnson4.58%22,500$5.50M••••••••••••••••••••••
4TMOThermo Fisher4.25%10,400$5.11M••••••••••••••••••••••
5MTDMettler-Toledo International Inc.3.99%3,800$4.79M••••••••••••••••••••••
6GILDGilead Sciences Inc3.48%30,000$4.18M••••••••••••••••••••••
7TEVA:ILTeva Pharmaceutical Industries Limited (Adr)3.26%130,000$3.92M••••••••••••••••••••••
8ISRGIntuitive Surg3.22%8,400$3.87M••••••••••••••••••••••
9ARGX:ASArgenx Se Spon Adr Each Rep 1 Ord Shs3.16%5,200$3.80M••••••••••••••••••••••
10ROIVRoivant Sciences Ltd2.88%125,000$3.46M••••••••••••••••••••••
Want to see all 41 holdings?View All HoldingsPRO

Top Holdings Themes

PharmaceuticalsBiotechnologyMedical DevicesLife Sciences ToolsBiotechnology ToolsData & AnalyticsManufacturingNetworking InfrastructureCybersecurityConnectors & InterconnectsImmunologyOncologyAging PopulationHealth & WellnessSocial Impact

BHCFX Mutual Fund Top Holdings

BHCFX holdings top 10 positions. The top 10 holdings account for 43.9% of the fund, led by Eli Lilly & Co at 9.9%, AstraZeneca PLC at 5.1%, Johnson & Johnson at 4.6%.

BHCFX portfolio concentration is moderate, with the top 10 representing 43.9% of total assets. The largest sector exposure is Health Care at 79.6%.

BHCFX sector allocation provides a detailed breakdown. BHCFX overlap tool shows how holdings compare to other funds in your portfolio.